protects patients
improves availability
delivers economic value and operational efficiencies
inactivate bacteria AND
viruses, protozoans, and leukocytes2
have a proven and established safety record3-7
day 1 release means potential for earlier receipt, resulting in younger, fresher platelets8
proactive approach to pandemic preparedness through inactivation of certain emerging
pathogens9-11
one transfusion-ready inventory for all patients that commands substantial hospital outpatient reimbursement2,8,12
avoid additional costs due to reduced risk of TTIs, sepsis and TA-GVHD13-14
protects patients
improves availability
delivers economic value and operational efficiencies